Dimensional Fund Advisors’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$680K Buy
+86,461
New +$608K ﹤0.01% 2927
2026
Q1
Sell
-23,757
Closed -$98.8K 3239
2025
Q4
$98.8K Sell
23,757
-19,884
-46% -$113K ﹤0.01% 3149
2025
Q3
$241K Sell
43,641
-9,990
-19% -$47.8K ﹤0.01% 3097
2025
Q2
$225K Hold
53,631
﹤0.01% 3099
2025
Q1
$256K Sell
53,631
-1,844
-3% -$9.39K ﹤0.01% 3098
2024
Q4
$211K Buy
+55,475
New +$405K ﹤0.01% 3159
2023
Q3
Sell
-3,182
Closed -$50.2K 3480
2023
Q2
$50.2K Sell
3,182
-8
-0.3% -$183 ﹤0.01% 3407
2023
Q1
$72.1K Buy
+3,190
New +$105K ﹤0.01% 3353
2022
Q3
$125K Sell
3,190
-2,686
-46% -$128K ﹤0.01% 3306
2022
Q2
$282K Sell
5,876
-3,413
-37% -$200K ﹤0.01% 3189
2022
Q1
$858K Sell
9,289
-465
-5% -$63.2K ﹤0.01% 3029
2021
Q4
$2.17M Buy
+9,754
New +$2.72M ﹤0.01% 2835

Other funds holding DTIL

Dimensional Fund Advisors's DTIL Position: Q2 2026 in Review

Dimensional Fund Advisors opened a new position in Precision BioSciences (DTIL) in Q2 2026: 86,461 shares worth $680K. The stake represents ﹤0.01% of the portfolio and ranks #2927 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in DTIL as recently as Q4 2025.

Dimensional Fund Advisors first reported a position in DTIL in Q4 2021 and has held it in 12 quarters since. The position peaked at $2.17M in Q4 2021. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Dimensional Fund Advisors held 86,461 shares of Precision BioSciences worth $680K as of Q2 2026.
  • Precision BioSciences was a new Dimensional Fund Advisors position in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2927 holding.
  • Dimensional Fund Advisors first reported a position in Precision BioSciences in Q4 2021 and has held it in 12 quarters since.
  • Dimensional Fund Advisors's Precision BioSciences position peaked at $2.17M in Q4 2021.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.